Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.91
Delayed Data
As of Dec 09
 -0.09 / -4.50%
Today’s Change
1.33
Today|||52-Week Range
5.19
-58.84%
Year-to-Date

Today’s Trading

Previous close2.00
Today’s open1.99
Day’s range1.89 - 2.05
Volume1,449,416
Average volume (3 months)880,891
Market cap$83.9M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-55.65%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
LIFEaTyr Pharma Inc+0.05+1.41%
TCONTRACON Pharmaceutica...-0.20-3.70%
SCYXSCYNEXIS Inc-0.03-0.85%
ORMPOramed Pharmaceutica...+0.15+2.40%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts


Search for Jobs